Business
Press Release Mar 22 2023
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated March 22, 2023, titled "Osteoarthritis Candidate MM-II Showed Durable Pain Relief in Global Phase 2b Study".
About this update from Sun Pharmaceutical Industries Limited
[{"type":"text","content":" Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated March 22, 2023, titled \"Osteoarthritis Candidate MM-II Showed Durable Pain Relief in Global Phase 2b Study\". View Attachment","length":354,"tagName":"div"}]